Condition: Autosomal Recessive Cerebellar Ataxia · Sponsor: University Hospital, Strasbourg, France
RADIAL is an algorithm which has been developed following a review of the literature on 67 autosomal recessive cerebellar ataxias (ARCA) and personal clinical experience. Frequency and specificity of each feature were defined for each autosomal recessive cerebellar ataxia, and corresponding prediction scores were assigned. Clinical and paraclinical features of patients are entered into the algorithm, and a patient's total score for each ARCA is calculated, producing a ranking of possible diagnoses. Sensitivity and specificity of the algorithm were assessed by blinded analysis of a multinational cohort of 834 patients with molecularly confirmed autosomal recessive cerebellar ataxia. The performance of the algorithm was assessed versus a blinded panel of autosomal recessive cerebellar ataxia experts. The correct diagnosis was ranked within the top 3 highest-scoring diagnoses at a sensitivity and specificity of \>90% for 84% and 91% of the evaluated genes, respectively. Mean sensitivity and specificity of the top 3 highest-scoring diagnoses were 92% and 95%, respectively. Our aim is now to validate in a prospective cohort of ARCA, the performance of RADIAL to predict the correct genetic diagnosis.
This description comes directly from the study's public registry record.
Tranchant Christine, MD · +33 3 88 12 85 31 · christine.tranchant@chru-strasbourg.fr
Always discuss trial participation with your own doctor first.
| CHU de Besancon- Neurology | Besançon, France | Recruiting |
| CHU de Dijon- Neurology | Dijon, France | Recruiting |
| CHU Lille- Neurology | Lille, France | Not Yet Recruiting |
| CHU Marseille- Neurology | Marseille, France | Recruiting |
| CHU Montpellier - Neurology | Montpellier, France | Recruiting |
| CHU Nancy- Neurology | Nancy, France | Recruiting |
| CHRU de Strasbourg - Neurology/Pediatrics | Strasbourg, France | Recruiting |
| CHU Toulouse- Neurology | Toulouse, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04261127